Table 3.
Characteristics of the patients correlated with expression of KMO protein.
| Characteristics | KMO | P value | ||
|---|---|---|---|---|
| Negative 0-3 | Weak 4-6 | Strong 7-9 | ||
| All patients | 6/ 86 (7%) | 41/86 (48%) | 39/86 (45%) | |
| Age | ||||
| <9 years | 4/6 (67%) | 12/41 (29%) | 6/39 (15%) | |
| ≥ 9 years | 2/6 (33%) | 29/41 (71%) | 33/39 (85%) | 0.271 |
| Tumor size | ||||
| ≤ 5 cm maximum diameter | 4/6 (67%) | 31/41 (76%) | 25/39 (64%) | |
| > 5 cm maximum diameter | 2/6 (33%) | 10/41 (24%) | 14/39 (36%) | 0.028∗ |
| Ovariohysterectomy status | ||||
| No | 5/6 (100%) | 37/41 (90%) | 18/39 (47%) | 0.031∗ |
| Yes | 1/6 (0%) | 4/41 (10%) | 21/39 (53%) | |
| Malignancy | ||||
| Benign | 6/6 (100%) | 31/41 (76%) | 12/39 (31%) | |
| Malignant | 0/6 (0%) | 10/41 (24%) | 27/39 (69%) | 0.0004∗∗ |
| Tumor stage (N=37) | ||||
| I, II and III | --- | 3/10 (30%) | 11/27 (41%) | |
| IV and V | --- | 7/10 (70%) | 16/27 (59%) | 0.046∗ |
| Lymph node metastasis | ||||
| No | --- | 7/10 (70%) | 16/27 (59%) | 0.208 |
| Yes | --- | 3/10 (30%) | 11/27 (41%) | |
| Distant metastasis | ||||
| No | --- | 8/10 (80%) | 24/27 (89%) | 0.951 |
| Yes | --- | 2/10 (20%) | 3/27 (11%) | |
| Recurrence | ||||
| No | 6/6 (100%) | 19/41 (46%) | 9/27 (33%) | |
| Yes | 0/6 (0%) | 22/41 (54%) | 18/27 (67%) | 0.025 ∗ |
∗P < 0.05; ∗∗P < 0.01.